Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Vesterqvist

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1992
Effect of the phospholipase A2 inhibitors quinacrine and 7,7-dimethyleicosadienoic acid in isolated globally ischemic rat heartsC A Sargent, O Vesterqvist, J R McCullough, et al.
Thrombosis Research|November 1, 1987
Hemostatic disturbances associated with implantation of an artificial heartK Gréen, J Liska, N Egberg, et al.
Contraception|February 1, 1983
Menses induction and second-trimester pregnancy termination using a polymeric controlled release vaginal delivery system containing (15S)15-methyl PGF2 alpha methyl esterM Bygdeman, N Christenssen, K Gréen, et al.
Analytical Biochemistry|March 1, 1994
Characterization of rabbit myocardial phospholipase A2 activity using endogenous phospholipid substratesO Vesterqvist, C A Sargent, G J Grover, et al.
Pflugers Archiv : European Journal of Physiology|December 1, 1984
The prostaglandin-analogue-9-deoxo-16,16-dimethyl-9-methylene-PGE2 inhibits the antidiuretic effect of vasopressin (AVP) in the conscious sheepN J Christensen, M Bygdeman, K Greén, et al.
Analytical Biochemistry|July 1, 1992
Quantitation of lysophosphatidylcholine molecular species in rat cardiac tissueO Vesterqvist, C A Sargent, S C Taylor, et al.
The American Journal of Geriatric Cardiology|June 21, 2001
Effects of age and gender on the pharmacodynamics of omapatrilat in healthy volunteersW Liao, O Vesterqvist, J Manning, et al.
Prostaglandins|May 1, 1989
An increase in the ratio of thromboxane A2 to prostacyclin in association with increased blood pressure in patients on cyclosporine AU Förstermann, K Kühn, O Vesterqvist, et al.
Journal of Clinical Pharmacology|January 5, 2002
Pharmacodynamics and pharmacokinetics of omapatrilat in heart failureJ B Kostis, M Klapholz, C Delaney, et al.
Hypertension (Dallas, Tex. : 1979)|December 26, 2001
Omapatrilat versus lisinopril: efficacy and neurohormonal profile in salt-sensitive hypertensive patientsV M Campese, K C Lasseter, C M Ferrario, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1992
Effect of the phospholipase A2 inhibitors quinacrine and 7,7-dimethyleicosadienoic acid in isolated globally ischemic rat heartsC A Sargent, O Vesterqvist, J R McCullough, et al.
Thrombosis Research|November 1, 1987
Hemostatic disturbances associated with implantation of an artificial heartK Gréen, J Liska, N Egberg, et al.
Contraception|February 1, 1983
Menses induction and second-trimester pregnancy termination using a polymeric controlled release vaginal delivery system containing (15S)15-methyl PGF2 alpha methyl esterM Bygdeman, N Christenssen, K Gréen, et al.
Analytical Biochemistry|March 1, 1994
Characterization of rabbit myocardial phospholipase A2 activity using endogenous phospholipid substratesO Vesterqvist, C A Sargent, G J Grover, et al.
Pflugers Archiv : European Journal of Physiology|December 1, 1984
The prostaglandin-analogue-9-deoxo-16,16-dimethyl-9-methylene-PGE2 inhibits the antidiuretic effect of vasopressin (AVP) in the conscious sheepN J Christensen, M Bygdeman, K Greén, et al.
Analytical Biochemistry|July 1, 1992
Quantitation of lysophosphatidylcholine molecular species in rat cardiac tissueO Vesterqvist, C A Sargent, S C Taylor, et al.
The American Journal of Geriatric Cardiology|June 21, 2001
Effects of age and gender on the pharmacodynamics of omapatrilat in healthy volunteersW Liao, O Vesterqvist, J Manning, et al.
Prostaglandins|May 1, 1989
An increase in the ratio of thromboxane A2 to prostacyclin in association with increased blood pressure in patients on cyclosporine AU Förstermann, K Kühn, O Vesterqvist, et al.
Journal of Clinical Pharmacology|January 5, 2002
Pharmacodynamics and pharmacokinetics of omapatrilat in heart failureJ B Kostis, M Klapholz, C Delaney, et al.
Hypertension (Dallas, Tex. : 1979)|December 26, 2001
Omapatrilat versus lisinopril: efficacy and neurohormonal profile in salt-sensitive hypertensive patientsV M Campese, K C Lasseter, C M Ferrario, et al.
Pageof 6